Alex Arfaei


Pappas Capital

Alex joined Pappas Capital in 2019, bringing with him twelve years of equity research experience and six years of biopharma operating experience. Prior to joining Pappas, he was a Managing Director with BMO Capital Markets where he was a top-ranked senior equity research analyst responsible for pharmaceutical and biotechnology companies. He began his career in the pharma industry with operating roles at Merck and Endo Pharmaceuticals. Alex has a BSc in Cell and Molecular Biology from the University of Toronto, and a MBA focusing on Health Sector Management from Duke University’s Fuqua School of Business.